Development of Anti-neutrophil Cytoplasmic Antibodies (ANCA) and Vasculitis in BALB/c Mice: A Prototype of Human ANCA Associated Disease

被引:0
|
作者
Pradhan, Vandana D. [1 ]
Ghosh, K. [1 ]
机构
[1] King Edward Mem Hosp, Indian Council Med Res, Natl Inst Immunohaematol, Dept Autoimmune Disorders, Mumbai 4000012, Maharashtra, India
关键词
Anti-neutrophil cytoplasmic antibodies (ANCA); BALB/c mice; vasculitis; myeloperoxidase (MPO); proteinase3 (PR3); GLOMERULONEPHRITIS; AUTOANTIBODIES; MYELOPEROXIDASE; MODEL;
D O I
10.1080/09712119.2009.9707080
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
To investigate whether immunization in BALB/c mice with ANCA will induce ANCA associated vasculitis that will serve as an animal model for the diseased mice were immunized with myeloperoxidase (MPO), proteinase3 (PR3) and 'a granule' extract of polymorphonuclear leukocytes (PMN) using purified human whole antibody to MPO and PR3 and also the F(ab')(2) fractions of MPO-ANCA and PR3-ANCA. Control mice were immunized with normal human IgG. Mice immunized with purified MPO and PR3 as well as with human IgG-ANCA and its F(ab')(2) fractions, developed ANCA and AAV, while control mice did not develop these autoantibodies or the disease. This ANCA could be induced in BALB/c mice by antigen and antibody immunizations and these mice showed the possible development of ANCA related vasculitis indicating a likely pathogenic role of ANCA.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 50 条
  • [41] Fatal haemorrhagic varicella in a patient with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
    Ben-Chetrit, E.
    Lachish, T.
    Nesher, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (01) : S95 - S95
  • [42] Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis
    Thickett, DR
    Richter, AG
    Nathani, N
    Perkins, GD
    Harper, L
    RHEUMATOLOGY, 2006, 45 (03) : 261 - 268
  • [43] Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis
    Niles, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 27 - 30
  • [44] Treatment Response Criteria for Anti-neutrophil Cytoplasmic Antibodies (ANCA)-vasculitis: Results of a Scoping Review
    Monti, Sara
    Quinn, Kaitlin
    Christensen, Robin
    Mahr, Alfred
    Pagnoux, Christian
    Langford, Carol
    Jayne, David
    Merkel, Peter
    Tomasson, Gunnar
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [45] Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitis
    Salama, Alan D.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (01): : 7 - 12
  • [46] Detection of ANCA (Anti-Neutrophil Cytoplasmic Antibodies) and related neurological diseases
    Aziz, S.
    Tahiri-Jouti, N.
    Ibn Moufti, R.
    Fellah, H.
    Oudghiri, M.
    Naya, A.
    Slassi, I.
    Zamiati, S.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2012, 27 (05): : 254 - 259
  • [47] Digital Ischemia, a Rare Manifestation in Anti-neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
    Vural, Adil
    Zhang, Chao
    Yaseen, Kinanah
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3032 - 3035
  • [48] Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis
    Cheng, L.
    Gou, S. -J.
    Qiu, H. -Y.
    Ma, L.
    Fu, P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01): : 116 - 124
  • [49] DO PATIENTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS (AAV) NEED ANTICOAGULANTS?
    Tarasova, G.
    Egorova, O.
    Kolomeychuk, A.
    Reshetnyak, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1436 - 1436
  • [50] Prevalence of anti-neutrophil cytoplasmic antibodies (ANCA) in juvenile chronic arthritis
    Speckmaier, M
    Rother, E
    Terreri, T
    Reiff, A
    Metzger, D
    Schuchmann, L
    Forster, J
    Peter, HH
    Brandis, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (02) : 211 - 216